Overview
Finland X-ray detector firm's Q4 net sales fell 6.1% yr/yr
Sales in medical applications rose 19.1%, driven by demand in China
Company expects double-digit sales growth in Q1 and H1 2026
Outlook
Detection Technology expects double-digit net sales growth in Q1 and H1 2026
Company aims for 10% annual sales growth and 15% operating margin medium term
Geopolitical tensions and U.S. tariffs create uncertainty for Detection Technology
Result Drivers
MEDICAL APPLICATIONS - Sales in medical applications grew 19.1%, driven by demand in China
SECURITY APPLICATIONS DECLINE - Sales in security applications decreased by 28.5% due to various one-off events
PRODUCT LAUNCHES - Co executed significant product launches, supporting future growth
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
EUR 29.69 mln
Q4 EPS
EUR 0.22
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Detection Technology Oyj is €12.00, about 11.6% above its February 4 closing price of €10.75
The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 15 three months ago
Press Release: ID:nWkr5sb0fc
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)